Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rikke Fredslund Andersen (Rikke F Andersen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Venues

Cancers

Cancer medicine

Vejle Hospital

Aarhus Universitet (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vejle Hospital Jun 1o 2007

Denmark

Molecular Biologist :: Dept. Clinical Immunology and Biochemistry

Education History

Aarhus Universitet

Denmark

MSC

Publications

Morten Borg, Sara Witting Christensen Wen, Rikke Fredslund Andersen, Signe Timm, Torben Frøstrup Hansen, Ole Hilberg
Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 15 (15) (2023)
Line Bechsgaard Andersen, Marit Sofie Kjær Mahler, Rikke Fredslund Andersen, Lars Henrik Jensen, Louise Raunkilde
The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab. Cancers 14 (19) (2022)
Louise Raunkilde, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Birgitte Mayland Havelund, Caroline Emilie B Thomsen, Lars Henrik Jensen
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer. Cancers 14 (18) (2022)
Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer. Cancers 14 (7) (2022)
Sara Witting Christensen Wen, Rikke Fredslund Andersen, Kristian Rasmussen, Caroline Emilie B Thomsen, Torben Frøstrup Hansen, Line Nederby, Henrik Hager, Anders Jakobsen, Ole Hilberg
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer. Cancers 13 (16) (2021)
Caroline Emilie B Thomsen, Ane Lindegaard Appelt, Rikke Fredslund Andersen, Jan Lindebjerg, Lars Henrik Jensen, Anders Jakobsen
The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer. Cancer medicine 6 (5) (2017)

Rikke Fredslund Andersen.css-eqlu8i{font-size:small;padding-left:4px;} (Rikke F Andersen)

Publication Activity (10 Years)

Top Topics

Top Venues

Rikke Fredslund Andersen (Rikke F Andersen)